Clinical players and healthcare payers

Aligning perspectives on the cost-effectiveness of next-generation sequencing in oncology

Brett Doble, Paula Lorgelly

Research output: Contribution to journalEditorialOtherpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)9-12
Number of pages4
JournalPersonalized Medicine
Volume12
Issue number1
DOIs
Publication statusPublished - 1 Jan 2015

Keywords

  • cancer
  • clinical tumor sequencing
  • cost-effectiveness analysis
  • economic evaluation
  • reimbursement
  • value assessment
  • whole-genome sequencing

Cite this

@article{7ce4b6954bdd435c862b74162384544d,
title = "Clinical players and healthcare payers: Aligning perspectives on the cost-effectiveness of next-generation sequencing in oncology",
keywords = "cancer, clinical tumor sequencing, cost-effectiveness analysis, economic evaluation, reimbursement, value assessment, whole-genome sequencing",
author = "Brett Doble and Paula Lorgelly",
year = "2015",
month = "1",
day = "1",
doi = "10.2217/pme.14.81",
language = "English",
volume = "12",
pages = "9--12",
journal = "Personalized Medicine",
issn = "1741-0541",
publisher = "Future Medicine",
number = "1",

}

Clinical players and healthcare payers : Aligning perspectives on the cost-effectiveness of next-generation sequencing in oncology. / Doble, Brett; Lorgelly, Paula.

In: Personalized Medicine, Vol. 12, No. 1, 01.01.2015, p. 9-12.

Research output: Contribution to journalEditorialOtherpeer-review

TY - JOUR

T1 - Clinical players and healthcare payers

T2 - Aligning perspectives on the cost-effectiveness of next-generation sequencing in oncology

AU - Doble, Brett

AU - Lorgelly, Paula

PY - 2015/1/1

Y1 - 2015/1/1

KW - cancer

KW - clinical tumor sequencing

KW - cost-effectiveness analysis

KW - economic evaluation

KW - reimbursement

KW - value assessment

KW - whole-genome sequencing

UR - http://www.scopus.com/inward/record.url?scp=84920816380&partnerID=8YFLogxK

U2 - 10.2217/pme.14.81

DO - 10.2217/pme.14.81

M3 - Editorial

VL - 12

SP - 9

EP - 12

JO - Personalized Medicine

JF - Personalized Medicine

SN - 1741-0541

IS - 1

ER -